PREV PreveCeutical Medical Inc.

0.0140USD0.0200 CAD · CNQ0.00%Mkt Cap: 8.92M USDP/E: —

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventi…

Key Statistics

Company
Market Cap8.92M USD
Enterprise Value12.28M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.18M USD
Revenue/Share—
Last Price0.0140 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA74143C1068
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.13
EV/Revenue—
P/S—
P/B-1.82
EPS (TTM)0.00 USD
EPS (Forward)—
52W Range
0.010511% of range0.0419
52W High0.0419 USD
52W Low0.0105 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE27.08%
ROA-116.73%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.20M USD
CapEx (TTM)2.07K USD
FCF Margin—
FCF Yield-20.26%
Net Debt3.36M USD
Net Debt/EBITDA-2.22
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.75
Current Ratio0.16
Quick Ratio0.01
Book Value/Sh-0.0077 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split5:1
Split DateMay 23, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.638.19M
Float490.19M
Insiders14.17%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.01%
Shares Short86.30K
Short (prev mo.)82.00K
Technical
SMA 500.0137 (+2.0%)
SMA 2000.0133 (+5.0%)
Beta0.38
S&P 52W Chg12.00%
Avg Vol (30d)262.74K
Avg Vol (10d)340.59K
Technical Indicators
RSI (14)51.7
MACD0.0007
MACD Signal0.0007
MACD Hist.+0.0000
BB Upper0.0168 USD
BB Middle0.0136 USD
BB Lower0.0105 USD
BB Width45.87%
ATR (14)0.0011 USD
Vol Ratio (20d)0.24x

About PreveCeutical Medical (CNSX: PREV)

›

PreveCeutical Medical (CNSX: PREV) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0200 CAD on 19 November 2026, down 42.9% over 52 weeks. Its 52-week range is 0.0150 CAD to 0.0600 CAD: the price is 66.7% below the high and 33.3% above the low.

Its market capitalisation is 12.76M CAD.

PreveCeutical Medical reports return on equity of 27.1% and an operating margin of 0.0%.

Its debt exceeds its cash by 4.81M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.